| Literature DB >> 31459900 |
Diogo Matias1,2, Marisa Nicolai1, Lucília Saraiva3, Rute Pinheiro3, Célia Faustino4, Ana Diaz Lanza2, Catarina Pinto Reis1,4, Tijana Stankovic5, Jelena Dinic5, Milica Pesic5, Patrícia Rijo1,4.
Abstract
Cytotoxicity screenings have identified Plectranthus plants as potential sources of antitumor lead compounds. In this work, several extracts from Plectranthus madagascariensis were prepared using different solvents (acetone, methanol, and supercritical CO2) and extraction techniques (maceration, ultrasound-assisted, and supercritical fluid extraction), and their chemical composition was detailed using high-performance liquid chromatography with a diode array detector. The cytotoxic activity of the major compounds identified, namely, rosmarinic acid (1) and abietane diterpenes 7α,6β-dihydroxyroyleanone (2), 7α-formyloxy-6β-hydroxyroyleanone (3), 7α-acetoxy-6β-hydroxyroyleanone (4), and coleon U (5), was evaluated in a battery of human cancer cell lines, including breast (MDA-MB-231, MCF-7), colon (HCT116), and lung (NCI-H460, NCI-H460/R) cancer, and also in healthy lung (MCR-5) cells. Royleanone (3) was isolated for the first time from P. madagascariensis, and its full spectroscopic characterization (proton and carbon nuclear magnetic resonance) was accomplished. A high selectivity for lung cancer cells was observed for royleanones (2, 4) with selectivity indexes of 4.3 and 3.2, respectively. The observed results combined with literature data allowed the establishment of important structure-activity relationships for substituted royleanone abietanes, such as the requirement for an electron-donating group at positions 6 and/or 7 in the abietane skeleton, and an improved cytotoxic effect for substituents with log P values between 2 and 5.Entities:
Year: 2019 PMID: 31459900 PMCID: PMC6648853 DOI: 10.1021/acsomega.9b00512
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Preparation, Yields, and Component Quantification of P. madagascariensis Extracts
| component
yield in extract (mg/g) | ||||||||
|---|---|---|---|---|---|---|---|---|
| extract | solvent | method | extraction yield (mg/g) | ( | ( | ( | ( | ( |
| E1 | acetone | UAE | 1.51 | 29.8 | 4.62 | 1.64 | 1.04 | 15.5 |
| E2 | acetone | ME | 1.45 | 17.5 | 3.19 | 6.74 | 1.21 | 5.77 |
| E3 | methanol | UAE | 6.56 | 4.60 | 4.20 | 0.81 | 0.77 | t |
| E4 | methanol | ME | 12.0 | 26.4 | 1.05 | 0.24 | t | t |
| E5 | scCO2 | SCFE | 1.31 | 17.8 | 4.98 | 0.20 | 0.84 | n/d |
| E6 | acetone | R-SCFE | 2.95 | 50.5 | 0.33 | 0.17 | n/d | n/d |
UAE, ultrasound-assisted extraction; ME, maceration extraction; SCFE, supercritical fluid extraction; R-SCFE, re-extraction of SCFE remaining plant material.
t, traces. n/d not detected. The extraction yield is express in mg of extract per g of plant dry material. The component yield is express in mg of component per g of plant dry material.
Figure 1Chemical structure of the major components in P. madagascariensis extracts: rosmarinic acid (1), 6β,7α-dihydroxyroyleanone (2), 7α-formyloxy-6β-hydroxyroyleanone (3), 7α-acetoxy-6β-hydroxyroyleanone (4), and coleon U (5).
Figure 2HPLC chromatogram showing the decomposition of coleon U (5) to coleon U quinone (6).
NMR Spectroscopic Data (400 MHz, CDCl3) for 7α-Formyloxy-6β-hydroxyroyleanone (3)
| position | δC, type | δH ( | HMBC |
|---|---|---|---|
| 1 | 38.49, CH2 | 1.19, s; 2.64, d (12.9) | |
| 2 | 19.09, CH2 | 1.50, m; 1.85, d (4.5) | |
| 3 | 42.45, CH2 | 1.20, 1.50, m | |
| 4 | 33.83, C | ||
| 5 | 49.80, CH | 1.38, s | 10 |
| 6α | 67.25, CH | 4.37, m | |
| 7β | 68.42, CH | 5.80, m | |
| 8 | 136.45, C | ||
| 9 | 150.38, C | ||
| 10 | 38.79, C | ||
| 11 | 183.34, C | ||
| 12 | 151.13, C | ||
| 13 | 124.35, C | ||
| 14 | 183.34, C | ||
| 15 | 24.34, CH | 3.17, qi (14.1; 7.1) | 13 |
| 16 | 33.85, CH3 | 1.24, d (7.1) | |
| 17 | 20.01, CH3 | 1.21, d (7.1) | 13 |
| 18 | 33.57, CH3 | 0.96, s | 3, 5, 19 |
| 19 | 23.97, CH3 | 1.25, s | 3, 5, 18 |
| 20 | 21.71, CH3 | 1.62, s | 1, 5 |
| 21 | 159.64, CH | 8.04, d (1.2) | |
| 6-OH ( | 2.31, t (7.5) | ||
| 12-OH ( | 7.20, m (3.1) |
Concentration of Major Compounds from P. madagascariensis Extracts Causing 50% Cell Growth Inhibition (GI50/μM) of Human Cell Linesa
| sulfurhodamine B (SRB) assay | MTT assay | ||||||
|---|---|---|---|---|---|---|---|
| cell line | |||||||
| compound | MDA-MB-231 | MCF-7 | HCT116 | NCI-H460 | NCI-H460/R | MCR-5 | SI |
| ( | >100 | nt | nt | >100 | >100 | >100 | |
| ( | >100 | ≥50 | 25 ± 2 | 25 ± 2 | 91 ± 13 | 4.3* | |
| ( | >100 | 7.9 ± 0.8§ | 7.9 ± 1.2 | 14.9 ± 2.9 | nt | nt | |
| ( | >100 | 6.4 ± 0.4#§ | 2.7 ± 0.4 | 3.1 ± 0.4 | 8.6 ± 0.4 | 3.2* | |
| ( | 46.9 | 5.5 ± 0.8#§ | 3.0 ± 0.2# | nt | nt | ||
| positive control | DOX 0.072 ± 0.0021 | DOX 0.16 ± 0.0018 | DOX 0.125 ± 0.0013 | PCX 0.0006 ± 0.0001 | PCX 0.117 ± 0.013 | PCX 0.523 ± 0.001 | PCX 872*** |
Selectivity index, SI = GI50(MCR-5)/GI50(NCI-H460). nt, not tested. #Previously reported results from our group.[11] Doxorubicin (DOX) was used as positive control in MDA-MB-231, MCF-7, and HCT116 cells. Paclitaxel (PCX) was used as positive control in NCI-H460, NCI-H460/R, and MCR-5 cells. Significant selectivity toward cancer cells: *p < 0.05, ***p < 0.001 (in NCI-H460, NCI-H460/R, and MCR-5 cells). §Values significantly different from compound (2), P < 0.05.
Cytotoxicity of Several Royleanone Derivatives against Different Cell Lines According to the Literaturea,b
| cell lines | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| compound
features | breast | CNS | colon | gastric | leukemia/lymphoma | melanoma | papilloma | pancreas | renal | lung | normal | melanoma | |||||||
| R1 | R2 | R3 | log | MCF-7[ | SF-268[ | HCT116[ | AGS[ | HL-60[ | P-388[ | U937[ | Molt-3[ | MEL-1[ | UACC-62[ | MV-3[ | KB[ | PaCa-2[ | TK-10[ | H460[ | MCR-5[ |
| OH | OH | OH | 0.85 | + | – | – | – | – | – | + | |||||||||
| OH | OCHO | OH | 0.97 | ++ | ++ | ++ | |||||||||||||
| OH | OCOCH3 | OH | 1.08 | ++ | + | + | + | + | +++ | ++ | +++ | ++ | |||||||
| OCOCH3 | OCOCH3 | OH | 1.31 | + | + | + | ++ | + | |||||||||||
| OCOCH3 | OCOCH3 | OCOCH3 | 1.54 | ++ | ++ | ++ | +++ | ++ | |||||||||||
| H | =O | OH | 1.57 | – | – | ||||||||||||||
| H | βOH | OH | 1.74 | – | + | ||||||||||||||
| H | OH | OH | 1.74 | + | +++ | + | + | + | + | ||||||||||
| OCOCH2CH3 | OCOCH3 | OH | 1.96 | + | + | ++ | ++ | ++ | |||||||||||
| H | OCOCH3 | OH | 1.97 | ++ | +++ | ||||||||||||||
| OH | OCH3 | OH | 2.10 | +++ | + | ||||||||||||||
| OH | OCOCH3 | OCOPh(4-NO2) | 2.30 | + | ++ | +++ | ++ | ++ | |||||||||||
| OCO(CH2)2CH3 | OCOCH3 | OH | 2.38 | ++ | ++ | +++ | +++ | +++ | |||||||||||
| HΔ[ | HΔ[ | OH | 2.51 | – | +++/+ | +++ | ++ | +/– | |||||||||||
| H | H | OH | 2.83 | – | – | – | + | – | – | – | + | ||||||||
| OCOCH2CH3 | OCOCH3 | OCOCH2CH3 | 2.85 | + | +++ | +++ | + | + | |||||||||||
| OH | OCOCH3 | OCOPh(4-CH3) | 3.69 | +++ | +++ | +++ | +++ | ++ | |||||||||||
| OH | OCOCH3 | OCOPh(4-Cl) | 3.77 | +++ | +++ | +++ | +++ | +++ | |||||||||||
| OCOPh(4-NO2) | OCOCH3 | OH | 4.31 | ++ | +++ | +++ | +++ | ++ | |||||||||||
| OCOPh | OCOCH3 | OCOPh | 5.33 | + | +++ | +++ | ++ | +++ | |||||||||||
| OCOPh(4-Cl) | OCOCH3 | OCOPh(4-Cl) | 6.45 | – | ++ | ++ | – | – | |||||||||||
| OH | O-FA | OH | >7 | – | – | – | – | – | |||||||||||
Unless otherwise stated, R2 conformation is β; FA, fatty acid; log P values estimated using ChemBioDraw; −, not active (GI50 > 30 μM); +, low cytotoxic (10 < GI50 ≤ 30 μM); ++, cytotoxic (5 < GI50 ≤ 10 μM); +++, highly cytotoxic (GI50 ≤ 5 μM); Ph, phenyl group.
References in square brackets.
See Figure for chemical structure.
Figure 3Proposed structure–activity relationships for 6,7,12-substituted royleanone-type abietane diterpenes based on data from Table .